Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Kindstar Globalgene Technology, Inc. ( (HK:9960) ) has shared an announcement.
Kindstar Globalgene Technology, Inc. announced a board meeting scheduled for March 28, 2025, to consider and approve the consolidated final results for the year ended December 31, 2024. The meeting will also address the potential recommendation of a final dividend and other business matters, indicating a focus on financial performance and shareholder returns.
More about Kindstar Globalgene Technology, Inc.
Kindstar Globalgene Technology, Inc. operates in the biotechnology industry, focusing on providing specialized diagnostic services. The company is incorporated in the Cayman Islands and is listed on the Hong Kong Stock Exchange.
YTD Price Performance: 20.34%
Average Trading Volume: 2,109,758
Technical Sentiment Consensus Rating: Hold
Current Market Cap: HK$1.44B
See more insights into 9960 stock on TipRanks’ Stock Analysis page.